Annual Drug Patent Expirations for RECORLEV
Recorlev is a drug marketed by Strongbridge and is included in one NDA. There are six patents protecting this drug.
This drug has twenty-eight patent family members in twenty countries.
The generic ingredient in RECORLEV is levoketoconazole. Additional details are available on the levoketoconazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
